Haiteng Jiang | Mental Health | Best Researcher Award

Dr. Haiteng Jiang | Mental Health | Best Researcher Award

Assistant professor, Zhejiang University, China

Dr. Haiteng Jiang is a Principal Investigator at the National Key Laboratory of Brain-Machine Intelligence, Zhejiang University, and an Assistant Professor at the Ministry of Education Frontier Science Center for Brain and Brain-Machine Integration, Zhejiang University. He specializes in the integration of brain functional imaging, genetic data, and speech signals to understand cognition and brain disorders. Dr. Jiang has significantly contributed to neuroscience research and clinical psychiatry with expertise in mental health screening, precision subtyping of psychiatric disorders, and novel neuromodulation techniques. His work spans across psychiatric and neurological diseases, combining computational modeling, neural modulation, and artificial intelligence to advance mental health care.

Profile

Education

Dr. Haiteng Jiang completed his PhD in Cognitive Artificial Intelligence at the Donders Institute for Brain, Cognition and Behaviour, Radboud University, The Netherlands (2011-2016). Prior to this, he obtained a Master’s degree in Biomedical Engineering from Southeast University, Nanjing, China (2008-2011). He earned his Bachelor’s degree in Electrical Engineering and Automation from Nanjing University of Posts and Telecommunication, Nanjing, China (2004-2008). His educational journey laid the foundation for his expertise in cognitive neuroscience and brain-machine integration, which he continues to advance through interdisciplinary research.

Experience

Dr. Haiteng Jiang is a Principal Investigator at Zhejiang University, where he leads several key projects in brain-machine intelligence, mental health screening, and neuromodulation techniques. He is also a faculty member at the Ministry of Education Frontier Science Center for Brain and Brain-Machine Integration. His postdoctoral experiences at Carnegie Mellon University (2018-2021) and the University of Minnesota (2016-2018) enhanced his research in biomedical engineering. Additionally, Dr. Jiang worked as an Assistant Researcher at Nanjing Brain Hospital (2016-2020). His research has been instrumental in integrating multimodal brain imaging and AI to advance the understanding and treatment of psychiatric and neurological disorders.

Awards and Honors

Dr. Haiteng Jiang has received numerous prestigious awards for his contributions to neuroscience and mental health research. Notably, he was awarded the Zhejiang University School of Medicine Li Zao Neuroscience Award in December 2022. He was also a recipient of the Excellent Young Scientists Fund (Overseas) from the National Natural Science Foundation of China in October 2022. Other significant honors include the Neuroscience Society Hot Topic Award (Top 1%) in 2018 and the Emerging Country Travel Scholar Award at the 21st International Biomagnetism Conference in 2018. Dr. Jiang’s work has been further supported through multiple overseas research fellowships and scholarships, such as those from Nijmegen University and the China Scholarship Council. His continued excellence in neuroscience and mental health has earned him widespread recognition in the scientific community.

Research Focus

Dr. Haiteng Jiang’s research is centered on systems neuroscience, with a focus on advancing mental health care through the integration of multimodal brain imaging, genetic information, and speech signals. He explores innovative ways to screen for psychiatric and psychological disorders using wearable devices and large language models. A key aspect of his research involves precision subtyping of psychiatric disorders by combining diverse types of data for accurate diagnosis. Additionally, Dr. Jiang investigates novel neuromodulation techniques to develop integrated therapeutic strategies for treating mental health disorders. His interdisciplinary approach combines experimental techniques, computational modeling, neural modulation, and artificial intelligence to address complex cognitive and brain disorders, including depression, epilepsy, and other neurological conditions.

Publication Top Notes

  • Measuring directionality between neuronal oscillations of different frequencies 🧠📊 Neuroimage 118, 359-367 (2015)
  • Predictability of depression severity based on posterior alpha oscillations 😞📉 Clinical Neurophysiology 127 (4), 2108-2114 (2016)
  • Noninvasive high-frequency oscillations riding spikes delineates epileptogenic sources ⚡🧠 PNAS 118 (17), e2011130118 (2021)
  • Interictal SEEG resting‐state connectivity localizes the seizure onset zone 🧠⚡ Advanced Science 9 (18), 2200887 (2022)
  • Mindfulness improves brain–computer interface performance by increasing control over neural activity in the alpha band 🧘‍♂️📊 Cerebral Cortex 31 (1), 426-438 (2021)
  • Formation of visual memories controlled by gamma power phase-locked to alpha oscillations 🧠🎯 Scientific Reports 6 (1), 28092 (2016)
  • Structural–functional decoupling predicts suicide attempts in bipolar disorder patients 🧠💔 Neuropsychopharmacology 45 (10), 1735-1742 (2020)
  • Brain–heart interactions underlying traditional Tibetan Buddhist meditation 🧘❤️ Cerebral Cortex 30 (2), 439-450 (2020)
  • Discriminating suicide attempters and predicting suicide risk 😞🔍 Frontiers in Psychiatry 11, 597770 (2020)
  • Hyperactive frontolimbic and frontocentral resting-state gamma connectivity in major depressive disorder 🧠💥 Journal of Affective Disorders 257, 74-82 (2019)

 

 

Shahnawaz Ali Bhat – Neuroscience – Best Researcher Award

Shahnawaz Ali Bhat - Neuroscience - Best Researcher Award

Aligarh Muslim University - India

AUTHOR PROFILE

SCOPUS

🧠 EXPERT IN THERAPEUTIC PEPTIDES AND HUNTINGTON’S DISEASE

Shahnawaz Ali Bhat, an esteemed researcher at Aligarh Muslim University, is dedicated to the field of molecular neuroscience. His work focuses on unraveling the complex interactions of therapeutic peptides, which offer significant potential in the treatment of Huntington’s disease. With a passion for finding innovative solutions to neurodegenerative disorders, his research is at the cutting edge of therapeutic development, exploring how these peptides can change the landscape of future treatments.

🔬 INVESTIGATING MITOCHONDRIAL STRUCTURE AND FUNCTION

In his role as an editorial leader, Shahnawaz has contributed extensively to understanding the proteins and protein complexes that influence mitochondrial structure and function. His editorial work on these topics delves into how mitochondrial dysfunction can lead to various diseases, offering insights into potential therapeutic interventions. This research is crucial for developing treatments for diseases linked to metabolic and structural mitochondrial abnormalities.

🌿 RESEARCHING WITHANIA SOMNIFERA (ASHWAGANDHA) FOR THERAPEUTIC POTENTIAL

Shahnawaz has a keen interest in the therapeutic properties of traditional medicines, particularly the molecular targets of Withania somnifera (Ashwagandha). His editorial contributions explore the potential of this ancient herb in treating a wide range of pathological conditions. By investigating its molecular interactions, he aims to uncover its role in modern medical applications, offering a bridge between traditional and contemporary medicine.

🧬 ADVANCING KNOWLEDGE IN PROTEIN COMPLEXES AND DISEASES

With a focus on the intricate relationships between proteins and diseases, Shahnawaz’s research explores how protein complexes influence disease progression. His work is aimed at unlocking the therapeutic potential of proteins, particularly in conditions like Huntington’s disease and other neurodegenerative disorders. His expertise in protein structures has made him a vital contributor to understanding how these biological systems can be manipulated for better health outcomes.

💡 BRIDGING MOLECULAR BIOLOGY AND THERAPEUTIC SOLUTIONS

Shahnawaz’s interdisciplinary approach combines molecular biology with therapeutic innovation. His research bridges the gap between understanding molecular mechanisms and developing practical solutions for treating complex diseases. By focusing on the underlying molecular pathways, he has contributed to a deeper understanding of how diseases can be effectively targeted and treated.

📖 EDITORIAL CONTRIBUTIONS TO SCIENTIFIC ADVANCEMENTS

As an editorial figure in several prestigious publications, Shahnawaz plays a crucial role in guiding scientific discussions in his field. His editorial work includes topics related to proteins, mitochondrial function, and therapeutic approaches, ensuring that cutting-edge research reaches a broad audience. His editorial influence extends the impact of his own research while fostering collaboration among scientists worldwide.

🌍 COMMITTED TO ADVANCING GLOBAL HEALTH

Driven by a commitment to improving global health outcomes, Shahnawaz Ali Bhat’s research and editorial contributions have a far-reaching impact. Whether investigating therapeutic peptides for neurodegenerative diseases or exploring the ancient wisdom of herbal medicines like Withania somnifera, his work is centered on enhancing human health. His contributions continue to shape the future of medical research and therapeutic development.

NOTABLE PUBLICATION

Title: The Emerging Landscape of Natural Small-molecule Therapeutics for Huntington’s Disease
Authors: Bhat, S.A., Ahamad, S., Dar, N.J., Siddique, Y.H., Nazir, A.
Journal: Current Neuropharmacology
Year: 2023

Title: The Emerging Landscape of Small-Molecule Therapeutics for the Treatment of Huntington's Disease
Authors: Ahamad, S., Bhat, S.A.
Journal: Journal of Medicinal Chemistry
Year: 2022

Title: Recent Update on the Development of PCSK9 Inhibitors for Hypercholesterolemia Treatment
Authors: Ahamad, S., Bhat, S.A.
Journal: Journal of Medicinal Chemistry
Year: 2022

Title: Proteinopathies: Deciphering Physiology and Mechanisms to Develop Effective Therapies for Neurodegenerative Diseases
Authors: Chopra, G., Shabir, S., Yousuf, S., Mir, A.H., Singh, M.P.
Journal: Molecular Neurobiology
Year: 2022

Title: Structure elucidation of a bimetallic μ-hydroxo-bridged Cu(II)-flufenamate-bpy complex and cytotoxic evaluation against MDA-MB-231 and A549 carcinoma cell lines
Authors: Yousuf, I., Mantoo, I.A., Bashir, M., Bhat, S.A.
Journal: Applied Organometallic Chemistry
Year: 2022